Literature DB >> 15933802

In elderly men and women treated for osteoporosis a low creatinine clearance of <65 ml/min is a risk factor for falls and fractures.

Laurent Dukas1, Erich Schacht, Hannes B Stähelin.   

Abstract

Recently, a low creatinine clearance (CrCl) of < 65 ml/min was described as a new significant and independent risk factor for the number of fallers and falls in a community-dwelling elderly population. In this study we investigated if a low creatinine clearance of < 65 ml/min is also a risk factor for falls and fractures in elderly men and women treated for osteoporosis. In a cross-sectional study with the help of questionnaires we assessed the prevalence of having experienced falls within the last 12 months according to renal function in 5,313 German men and women receiving treatment for osteoporosis. The CrCl was calculated using the established Cockcroft-Gault formula. The prevalence of falls and fractures was assessed in multivariate-controlled logistic regression models according to a CrCl cut off of 65 ml/min. The P-values were two-sided. In this study of elderly men and women treated for osteoporosis (n=5,313), 60.9% (n=3,238) had a CrCl of < 65 ml/min, which was associated in multivariate controlled analyses, compared to a CrCl of > or = 65 ml/min (n=2,075), with a significant increased risk of experiencing falls (1,775/3,238 vs. 773/2,075, OR 1.69, 95% CI 1.50-1.91, P<0.0001) and an increased risk for multiple falls (37.1 vs. 22.6%, OR 1.63, 95% CI 1.42-1.87, P<0.0001). Furthermore, compared to a creatinine clearance of > or = 65 ml/min, a creatinine clearance of < 65 ml/min was also associated with a significant increased multivariate controlled risk for hip fractures (OR 1.57, 95%CI 1.18-2.09, P=0.002), for radial fractures (OR 1.79, 95%CI 1.39-2.31, P=<0.0001), for total vertebral fractures (OR 1.31, 95%CI 1.19-1.55, P=0.003) and for fall-associated vertebral fractures (OR 1.24, 95% CI 1.03-1.54, P=0.031). Similar to community-dwelling elderly, in elderly men and women treated for osteoporosis a CrCl of less than 65 ml/min is a significant and independent risk factor for falls. Furthermore, we could show for the first time that a low creatinine clearance in elderly men and women treated for osteoporosis is also associated with a significantly increased risk of vertebral, hip and radial fractures.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15933802     DOI: 10.1007/s00198-005-1903-7

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  40 in total

1.  Falls relate to vitamin D and parathyroid hormone in an Australian nursing home and hostel.

Authors:  M S Stein; J D Wark; S C Scherer; S L Walton; P Chick; M Di Carlantonio; J D Zajac; L Flicker
Journal:  J Am Geriatr Soc       Date:  1999-10       Impact factor: 5.562

2.  The influence of age on bone mineral regulating hormones.

Authors:  S Epstein; G Bryce; J W Hinman; O N Miller; B L Riggs; S L Hui; C C Johnston
Journal:  Bone       Date:  1986       Impact factor: 4.398

3.  Neuromuscular and psychomotor function in elderly subjects who fall and the relationship with vitamin D status.

Authors:  J K Dhesi; L M Bearne; C Moniz; M V Hurley; S H D Jackson; C G Swift; T J Allain
Journal:  J Bone Miner Res       Date:  2002-05       Impact factor: 6.741

4.  Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.

Authors:  J C Gallagher; S E Fowler; J R Detter; S S Sherman
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

Review 5.  Use of oral corticosteroids and risk of fractures.

Authors:  T P Van Staa; H G Leufkens; L Abenhaim; B Zhang; C Cooper
Journal:  J Bone Miner Res       Date:  2000-06       Impact factor: 6.741

6.  A randomized, controlled trial of quadriceps resistance exercise and vitamin D in frail older people: the Frailty Interventions Trial in Elderly Subjects (FITNESS).

Authors:  Nancy K Latham; Craig S Anderson; Arier Lee; Derrick A Bennett; Anne Moseley; Ian D Cameron
Journal:  J Am Geriatr Soc       Date:  2003-03       Impact factor: 5.562

Review 7.  The divergent effects of tumour necrosis factor-alpha on skeletal muscle: implications in wasting.

Authors:  J M Argilés; B Alvarez; N Carbó; S Busquets; M Van Royen; F J López-Soriano
Journal:  Eur Cytokine Netw       Date:  2000-12       Impact factor: 2.737

8.  Fractures in rheumatoid arthritis: an evaluation of associated risk factors.

Authors:  B A Michel; D A Bloch; F Wolfe; J F Fries
Journal:  J Rheumatol       Date:  1993-10       Impact factor: 4.666

9.  Treatment with alfacalcidol in elderly people significantly decreases the high risk of falls associated with a low creatinine clearance of <65 ml/min.

Authors:  Laurent Dukas; Erich Schacht; Ze'ev Mazor; Hannes B Stähelin
Journal:  Osteoporos Int       Date:  2004-06-17       Impact factor: 4.507

10.  Tumor necrosis factor-alpha production is associated with less body cell mass in women with rheumatoid arthritis.

Authors:  Joseph Walsmith; Leslie Abad; Joseph Kehayias; Ronenn Roubenoff
Journal:  J Rheumatol       Date:  2004-01       Impact factor: 4.666

View more
  39 in total

1.  Fracture risk in CKD.

Authors:  Kristine E Ensrud
Journal:  Clin J Am Soc Nephrol       Date:  2013-07-11       Impact factor: 8.237

2.  Increased low-density lipoprotein cholesterol level is associated with non-vertebral fractures in postmenopausal women.

Authors:  Mika Yamauchi; Toru Yamaguchi; Kiyoko Nawata; Ken-ichiro Tanaka; Shin Takaoka; Toshitsugu Sugimoto
Journal:  Endocrine       Date:  2014-05-23       Impact factor: 3.633

Review 3.  Renal senescence in 2008: progress and challenges.

Authors:  Xin J Zhou; Ramesh Saxena; Zhihong Liu; N D Vaziri; Fred G Silva
Journal:  Int Urol Nephrol       Date:  2008-06-27       Impact factor: 2.370

4.  Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density.

Authors:  Richard Eastell; Dennis M Black; Steven Boonen; Silvano Adami; Dieter Felsenberg; Kurt Lippuner; Steven R Cummings; Pierre D Delmas; Lisa Palermo; Peter Mesenbrink; Jane A Cauley
Journal:  J Clin Endocrinol Metab       Date:  2009-06-30       Impact factor: 5.958

5.  Cystatin-C, renal function, and incidence of hip fracture in postmenopausal women.

Authors:  Andrea Z LaCroix; Jennifer S Lee; LieLing Wu; Jane A Cauley; Michael G Shlipak; Susan M Ott; John Robbins; J David Curb; Meryl Leboff; Douglas C Bauer; Rebecca D Jackson; Charles L Kooperberg; Steven R Cummings
Journal:  J Am Geriatr Soc       Date:  2008-07-24       Impact factor: 5.562

6.  Independent from muscle power and balance performance, a creatinine clearance below 65 ml/min is a significant and independent risk factor for falls and fall-related fractures in elderly men and women diagnosed with osteoporosis.

Authors:  L Dukas; E Schacht; M Runge
Journal:  Osteoporos Int       Date:  2009-09-22       Impact factor: 4.507

Review 7.  Chronic kidney disease and bone fracture: a growing concern.

Authors:  Thomas L Nickolas; Mary B Leonard; Elizabeth Shane
Journal:  Kidney Int       Date:  2008-06-18       Impact factor: 10.612

8.  Fracture risk in type 2 diabetes: update of a population-based study.

Authors:  L Joseph Melton; Cynthia L Leibson; Sara J Achenbach; Terry M Therneau; Sundeep Khosla
Journal:  J Bone Miner Res       Date:  2008-08       Impact factor: 6.741

9.  Factors affecting postoperative activities of daily living in patients with osteoporotic vertebral collapse with neurological deficits.

Authors:  Masafumi Kashii; Ryoji Yamazaki; Tomoya Yamashita; Shinya Okuda; Takahito Fujimori; Yukitaka Nagamoto; Yuichi Tamura; Takenori Oda; Tetsuo Ohwada; Motoki Iwasaki; Hideki Yoshikawa
Journal:  J Bone Miner Metab       Date:  2014-07-06       Impact factor: 2.626

10.  Pentosidine and increased fracture risk in older adults with type 2 diabetes.

Authors:  Ann V Schwartz; Patrick Garnero; Teresa A Hillier; Deborah E Sellmeyer; Elsa S Strotmeyer; Kenneth R Feingold; Helaine E Resnick; Frances A Tylavsky; Dennis M Black; Steven R Cummings; Tamara B Harris; Douglas C Bauer
Journal:  J Clin Endocrinol Metab       Date:  2009-04-21       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.